EPID-15FAMILIAL PREDISPOSITION TO HIGH GRADE ASTROCYTOMA
نویسندگان
چکیده
منابع مشابه
Salvage chemotherapy in progressive high-grade astrocytoma.
INTRODUCTION Despite aggressive multidisciplinary interventions, patients with high-grade astrocytomas experience tumour progression or recurrence. Treatment for this group of patients remains a formidable challenge. We describe our experience of salvage chemotherapy for these patients. MATERIALS AND METHODS A retrospective review of relevant clinical and radiographic information of patients ...
متن کاملTreatment Outcome of Supratentorial High Grade Astrocytoma and Glioblastoma Multiform
Purpose: The study was initiated to obtain epidemiologic data and information on anatomic distribution, clinical features and treatment results in patients with primary supratentorial anaplastic astrocytoma and glioblastoma multiform. Patients and Methods: Between January 2000 and January 2006, 113 primary high grade astrocytoma patients were eligible to evaluate clinical features. Radiotherapy...
متن کاملUsing a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy.
Based on clinical presentation, glioblastoma (GBM) is stratified into primary and secondary types. The protein 53 (p53) pathway is functionally incapacitated in most GBMs by distinctive type-specific mechanisms. To model human gliomagenesis, we used a GFAP-HRas(V12) mouse model crossed into the p53ER(TAM) background, such that either one or both copies of endogenous p53 is replaced by a conditi...
متن کاملMolecular markers relating to malignant progression in Grade II astrocytoma.
OBJECT Astrocytoma may progress rapidly or remain stable for many years. To clarify whether molecular characteristics could be prognostic factors, several cell cycling-associated molecular alterations in the diffuse astrocytoma have been investigated. METHODS Thirty-three patients in whom WHO Grade II astrocytoma had been initially diagnosed were assigned to 1 of 3 groups. Group 1 consisted o...
متن کاملMeta-analytic re-evaluation of misonidazole in the treatment of high grade astrocytoma.
BACKGROUND The clinical effects of the radiation sensitizer, misonidazole, in the treatment of high grade astrocytoma are equivocal based on available clinical trial data. A meta-analysis was performed in order to evaluate the impact of this compound on treatment outcome for this disease. METHODS One year survival data derived from over 1,700 patients enrolled in 9 randomized clinical trials ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Neuro-Oncology
سال: 2015
ISSN: 1522-8517,1523-5866
DOI: 10.1093/neuonc/nov213.15